Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - SHORT-TERM INVESTMENTS
Short-term Investments HALO - Halozyme Therapeutics, Inc.
218 M
LAST VALUE
-40.86%
2 YEAR CAGR
-6.00%
5 YEAR CAGR
17.30%
10 YEAR CAGR